EBITDA

PAD is set to go public via a SPAC deal, fueled by contracts with SpaceX and the DoD. We explore the tech, strategy, and market impact of this move.

A four-legged robot powered by physical AI is set to revolutionize heavy industry by tackling the welder shortage and bringing automation to the field.

The new platform moves beyond generative AI, using autonomous 'agents' to manage campaigns, monitor markets, and ensure enterprise-grade security.

A Boston biotech says its new AI platform moves beyond correlation to find the true biological causes of disease, promising a new era for medicine.

As Cimpress preps its Q3 results, investors watch to see if record growth can be sustained amid margin pressures in the booming custom print market.

A new coalition launches to combat regulatory hurdles and data rules in the Indo-Pacific, escalating economic tensions and targeting key Asian markets.

A partnership between myTomorrows and Rare Disease Research uses AI to streamline patient access to critical studies, offering new hope for families.

From $1,300 DIY setups to $100K+ labs, a new guide offers a crucial roadmap for researchers navigating the complex, costly world of VR investment.

A new clinical trial validates the Leva Pelvic Health System, offering a discreet, effective at-home treatment for a condition affecting millions of women.

With a massively oversubscribed €600M hybrid note offering, plant-based leader Roquette secures major funding and a huge vote of investor confidence.

A novel immunotherapy tames a potent but toxic cancer-fighting agent by locking it inside tumors, offering new hope for patients with resistant cancers.

As dating app fatigue grows and traditional matchmaking costs soar 26%, a new breed of affordable, human-led services is gaining traction with singles.

Quintara Biosciences launches AmpValue, a $4.99 overnight sequencing service set to disrupt biotech by making advanced, full-length data accessible to all.

A New York conference aims to fix the fragmented US e-invoicing market, promising billions in savings and enhanced security for American businesses.

A Swiss startup claims its new system offers deterministic control over AI art, moving beyond ambiguous text prompts. Is this the future of creation?

A new AI platform is revolutionizing how pharma creates complex scientific videos, earning industry award recognition for its speed, savings, and compliance.

A groundbreaking technology in China is set to revolutionize drug development by revealing atomic structures from previously unseeable nanocrystals.

Uranium Royalty Corp. is acquiring Sweetwater Royalties, combining high-growth uranium assets with stable soda ash cash flow in a landmark transaction.

With the strategic hire of Karl Kohler as CRO, Mail Metrics signals a major push for European dominance in customer communications, eyeing a $1B valuation.

A new $15M contract funds PlanetiQ's advanced satellites, giving the U.S. Air Force an unprecedented strategic edge with next-generation weather data.